Skip navigation

Currently Being Moderated

Ronan Pensec: And the Winner Is...

Posted by ActiveTdF on Jul 25, 2007 9:48:00 AM



I honestly think that the Tour is over and that Rasmussen is going to wear the yellow jersey in Paris. However, the end of the race will be tough for him. People along the road today were whistling at him and telling him things I won’t translate here. It is really like no one wants to see him win anymore with all these drug-taking problems.


The atmosphere is more than tense, it is really bad. Everybody is tired of all these problems and they all pretty much want to be at the end already. It’s really sad for cycling but we only get what we deserve as we hear around here.


So, today’s stage wasn’t amazing at all. I was expecting a strong stage from the Discovery team to boost Contador but it never happened. Contador wasn’t as fine as he was two days ago. And I guess also that all these talks and issues are disturbing the athletes anyway. I guess this is why the race was a bit disappointing today.


Today another rider got controlled positive for testosterone--Moreni from the Cofidis team. Testosterone...when you think about it, how can we still try to use these products? I don’t know what the riders were thinking about before this Tour. If they did think...


So, the only thing we can tell about today is that the Tour is over and the jerseys are pretty much settled. Boonen will get the green and Rasmussen the yellow.


I was really excited at the beginning of this Tour as I thought that teams, staff, riders and event organizers understood that this Tour was the right one to get the cycling back on the right track. I’m sad to note that it is definitely not the case.


I hope you are still enjoying the show anyway. Feel free to ask me any question. I will be glad to answer you.



Ronan Pensec participated in 8 Tours, and wore the yellow jersey in the 1990. He now operates Ronan Pensec Events, an official Tour de France operator hosting VIP cycling tours for recreational cycling enthusiasts.

Comments (4)